JCHOR
Journal of Current Hematology & Oncology Research

The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

eISSN: 2980-0854
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Case Report
Donor cell leukemia after allogeneic hematopoietic stem cell transplantation: a case report
Abstract
A 48-year-old man was diagnosed Acute myeloid leukemia with FLT3 ITD positive and PML/RAR?- negative. Remission was achieved after induction and consolidation chemotherapy. Allogeneic hematopoietic stem cell transplantation was performed from his full matched sibling donor. He relapsed after 5 years and his bone marrow examination revealed PML/RAR?- positive Acute promyelocytic leukemia. t(15:17) was positive and FLT-3 ITD was negative. Cytogenetic and molecular analysis confirmed donor cell origin. Donor didn’t develop Acute promyelocytic leukemia.

Keywords : Allogeneic stem cell transplantation, donor cell leukemia, leukemogenesis

Download Article


1. Reichard KK, Zhang QY, Sanchez L, Hozier J, Viswanatha D, Foucar K.Acute myeloid leukemia of donor origin after allogeneic bone marrowtransplantation for precursor T-cell acute lymphoblastic leukemia: casereport and review of the literature. Am J Hematol. 2006;81(3):178-185.doi:10.1002/ajh.20389
2. Cooley LD, Sears DA, Udden MM, Harrison WR, Baker KR. Donor cellleukemia: report of a case occurring 11 years after allogeneic bone marrowtransplantation and review of the literature. Am J Hematol. 2000;63(1):46-53. doi:10.1002/(sici)1096-8652(200001)63:1<46::aid-ajh11>3.0.co;2-f
3. Lowsky R, Fyles G, Minden M, et al. Detection of donor cell derivedacute myelogenous leukaemia in a patient transplanted for chronicmyelogenous leukaemia using fluorescence in situ hybridization. Br JHaematol. 1996;93(1):163-165. doi:10.1046/j.1365-2141.1996.454991.x
4. Cransac M, Boiron JM, Merel P, et al. Burkitt-type acute lymphoblasticleukemia in donor cells after allogeneic bone marrow transplantationfor acute nonlymphoblastic leukemia. Transplantation. 1993;56(1):120-123. doi:10.1097/00007890-199307000-00022
5. Feig SA, Dreazen O, Simon M, Wiley F, Schreck R, Gale RP. B cell acutelymphoblastic leukemia (ALL) in donor cells following bone marrowtransplantation for T cell ALL. Bone Marrow Transplant. 1988;3(4):331-337.
6. Browne PV, Lawler M, Humphries P, McCann SR. Donor-cell leukemiaafter bone marrow transplantation for severe aplastic anemia. N Engl JMed. 1991;325(10):710-713. doi:10.1056/NEJM199109053251007
7. Katz F, Reeves BR, Alexander S, Kearney L, Chessells J. Leukaemiaarising in donor cells following allogeneic bone marrow transplantationfor beta thalassaemia demonstrated by immunological, DNA andmolecular cytogenetic analysis. Br J Haematol. 1993;85(2):326-331.doi:10.1111/j.1365-2141.1993.tb03174.x
8. Sala-Torra O, Hanna C, Loken MR, et al. Evidence of donor-derivedhematologic malignancies after hematopoietic stem cell transplantation.Biol Blood Marrow Transplant. 2006;12(5):511-517. doi:10.1016/j.bbmt.2006.01.006
9. Flynn CM, Kaufman DS. Donor cell leukemia: insight into cancer stemcells and the stem cell niche. Blood. 2007;109(7):2688-2692. doi:10.1182/blood-2006-07-021980
10. Metcalfe JA, Parkhill J, Campbell L, et al. Accelerated telomereshortening in ataxia telangiectasia. Nat Genet. 1996;13(3):350-353.doi:10.1038/ng0796-350
11. Loren AW, Porter DL, Stadtmauer EA, Tsai DE. Post-transplantlymphoproliferative disorder: a review. Bone Marrow Transplant.2003;31(3):145-155. doi:10.1038/sj.bmt.1703806
12. Ho M, Miller G, Atchison RW, et al. Epstein-Barr virus infections andDNA hybridization studies in posttransplantation lymphoma andlymphoproliferative lesions: the role of primary infection. J Infect Dis.1985;152(5):876-886. doi:10.1093/infdis/152.5.876
13. Harris NL, Swerdlow SH, Frizzera G, Knowles DM. Post transplantlymphoproliferative disorders. In: Jaffe ES, Harris NL, Stein H,Vardiman JW, editors. World Health Organization classificationof tumors. Pathology and genetics of tumors of hematopoietic andlymphoid tissues. Lyon: IARC Press; 2001. p. 264-70.
14. Raaijmakers MH, Mukherjee S, Guo S, et al. Bone progenitordysfunction induces myelodysplasia and secondary leukaemia. Nature.2010;464(7290):852-857. doi:10.1038/nature08851
Article available in :
Volume 1, Issue 2, 2023
Page : 47-48
https://doi.org/10.51271/JCHOR-0011
Article Information
Received : 24 Mar 2023
Accepted : 24 Nis 2023
Published : 29 May 2023
Corresponding Author :

Serhat Çelik: Yıldırım Beyazıt University Yenimahalle Training and Research Hospital, Hematology Clinic, Ankara, Türkiye

[email protected]
Citation : Abedi AH, Çelik S, Özçelik Yılmaz ZD, Güven ZT, Akalın H, Kaynar L. Donor cell leukemia after allogeneic hematopoietic stem cell transplantation: a case report. J Curr Hematol Oncol Res. 2023;1(2):47-48.

Read: 290
Cited: 0
Download : 231
_Footer